Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | butyrylcholinesterase | Starlite/ChEMBL | References |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Homo sapiens | acetylcholinesterase (Yt blood group) | Starlite/ChEMBL | References |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Rattus norvegicus | Acetylcholinesterase | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0096 | 0.5 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.0096 | 0.0096 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.0096 | 0.0096 |
Trichomonas vaginalis | carboxylesterase domain containing protein, putative | 0.0041 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0096 | 0.5 |
Onchocerca volvulus | 0.0041 | 0 | 0.5 | |
Brugia malayi | Carboxylesterase family protein | 0.0246 | 1 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.5031 | 0.5031 |
Loa Loa (eye worm) | acetylcholinesterase 1 | 0.0246 | 1 | 1 |
Echinococcus granulosus | acetylcholinesterase | 0.0246 | 1 | 1 |
Echinococcus granulosus | carboxylesterase 5A | 0.0246 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0096 | 0.5 |
Echinococcus multilocularis | acetylcholinesterase | 0.0246 | 1 | 1 |
Onchocerca volvulus | 0.0041 | 0 | 0.5 | |
Onchocerca volvulus | 0.0041 | 0 | 0.5 | |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.0096 | 0.0096 |
Echinococcus granulosus | acetylcholinesterase | 0.0246 | 1 | 1 |
Trichomonas vaginalis | spcc417.12 protein, putative | 0.0041 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0246 | 1 | 1 |
Loa Loa (eye worm) | carboxylesterase | 0.0246 | 1 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.0096 | 0.0096 |
Onchocerca volvulus | 0.0041 | 0 | 0.5 | |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.5031 | 0.5031 |
Mycobacterium tuberculosis | POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) | 0.0041 | 0 | 0.5 |
Onchocerca volvulus | 0.0041 | 0 | 0.5 | |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0246 | 1 | 1 |
Mycobacterium tuberculosis | POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) | 0.0041 | 0 | 0.5 |
Echinococcus multilocularis | acetylcholinesterase | 0.0246 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0246 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0043 | 0.0096 | 0.0096 |
Mycobacterium tuberculosis | Carboxylesterase LipT | 0.0041 | 0 | 0.5 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.5031 | 0.5031 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0096 | 0.5 |
Echinococcus multilocularis | carboxylesterase 5A | 0.0246 | 1 | 1 |
Mycobacterium ulcerans | carboxylesterase, LipT | 0.0041 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 18.8 nM | Inhibition of human whole RBC AChE pretreated for 30 mins by Ellman technique | ChEMBL. | 20627738 |
IC50 (binding) | = 37.5 nM | Inhibition of rat brain homogenate AchE | ChEMBL. | 16735118 |
IC50 (binding) | = 37.5 nM | Inhibition of rat brain homogenate AchE | ChEMBL. | 16735118 |
IC50 (binding) | = 42.1 nM | Inhibition of human serum AchE | ChEMBL. | 16735118 |
IC50 (binding) | = 42.1 nM | Inhibition of human serum AchE | ChEMBL. | 16735118 |
IC50 (binding) | = 60 nM | Inhibition of human plasma BChE pretreated for 30 mins by Ellman technique | ChEMBL. | 20627738 |
IC50 (binding) | = 41.1 uM | Inhibition of electric eel AchE | ChEMBL. | 16735118 |
IC50 (binding) | = 41.1 uM | Inhibition of electric eel AchE | ChEMBL. | 16735118 |
IC50 (binding) | = 69.1 uM | Inhibition of acetylcholine esterase (unknown origin) using acetylthiocholine as substrate incubated for 15 mins prior to substrate addition measured after 5 mins by spectrophotometry | ChEMBL. | 23603045 |
Inhibition (binding) | Inhibition of human LAL at 10 uM after 30 mins by fluorescence assay | ChEMBL. | 20557099 | |
LD50 (ADMET) | = 0.51 mg kg-1 | Acute toxicity in ip dosed mouse measured after 72 hrs | ChEMBL. | 27377327 |
Potency (functional) | 0.3162 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 2.9362 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 6.5131 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | = 56.2341 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
17 literature references were collected for this gene.